[BLFS] BioLife Solutions, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 1.64 Change: 0.02 (1.23%)
Ext. hours: Change: 0 (0%)

chart BLFS

Refresh chart

Strongest Trends Summary For BLFS

BLFS is in the long-term up 871% in 4 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: BioLife Solutions, Inc. develops, manufactures, and markets patented hypothermic storage and cryopreservation solutions for cells and tissues. The company?s products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, delayed-onset cell damage, and death. Its HypoThermosol series of products include HypoThermosol FRS, a solution formulated to decrease the free radical accumulation in cells undergoing prolonged hypothermic preservation; and PrepaStor, a flush solution designed for use during the transitions from normothermic to mild hypothermic conditions to rinse culture media and native fluids from tissue and whole organ systems prior to suspension in a preservation solution. The company?s CryoStor series of products consist of CryoStor CS2, CryoStor CS5, and CryoStor CS10, which are cryopreservation freeze media products designed to mitigate temperature-induced molecular cell stress responses during freezing and thawing. Its BloodStor products comprise BloodStor 5

Fundamental Ratios
Shares Outstanding EPS-0.51 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 23.84% Sales Growth - Q/Q-10.12% P/E-4.47
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-24.33% ROE-34.04% ROI
Current Ratio7.49 Quick Ratio6.64 Long Term Debt/Equity Debt Ratio0.14
Gross Margin53.57% Operating Margin-69.82% Net Profit Margin-65.57% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities20 K Cash From Investing Activities1.72 M Cash From Operating Activities-1.31 M Gross Profit880 K
Net Profit-1.03 M Operating Profit-1.16 M Total Assets15.16 M Total Current Assets10.96 M
Total Current Liabilities1.46 M Total Debt Total Liabilities4.32 M Total Revenue1.5 M
Technical Data
High 52 week25.48 Low 52 week9.5 Last close17 Last change-8.36%
RSI37.64 Average true range1.07 Beta0.27 Volume54.9 K
Simple moving average 20 days-6.86% Simple moving average 50 days-3.99% Simple moving average 200 days8.82%
Performance Data
Performance Week-7.61% Performance Month-1.39% Performance Quart2.6% Performance Half5.85%
Performance Year-17.91% Performance Year-to-date41.31% Volatility daily3.55% Volatility weekly7.93%
Volatility monthly16.25% Volatility yearly56.28% Relative Volume505.82% Average Volume194.62 K
New High New Low

News

2019-09-16 08:00:00 | BioLife Solutions Announces New evo® Cold Chain Customers

2019-09-11 22:15:02 | Biolife Solutions Inc BLFS President & CEO Michael Rice Sold $553,992 of Shares

2019-09-06 22:15:02 | Biolife Solutions Inc BLFS CFO Greef Roderick De Sold $593,400 of Shares

2019-09-03 08:00:00 | Mustang Bio Adopts CryoStor® Freeze Media and evo® Cold Chain System for Cell and Gene Therapy Manufacturing and Distribution

2019-08-28 08:00:00 | BioLife Solutions Strengthens Sales Team with Key Leadership Additions

2019-08-12 08:00:00 | BioLife Solutions to Attend and Present at Upcoming Scientific and Investor Conferences

2019-08-10 21:12:13 | Edited Transcript of BLFS earnings conference call or presentation 8-Aug-19 8:30pm GMT

2019-08-08 23:23:47 | Biolife Solutions Inc BLFS Q2 2019 Earnings Call Transcript

2019-08-08 16:05:00 | BioLife Solutions Announces Second Quarter 2019 Financial Results

2019-08-08 08:05:00 | BioLife Solutions Completes Acquisition of SAVSU Technologies

2019-08-02 22:15:03 | Biolife Solutions Inc BLFS CFO Greef Roderick De Sold $568,800 of Shares

2019-08-01 10:33:02 | BioLife Solutions BLFS Expected to Beat Earnings Estimates: Can the Stock Move Higher?

2019-07-31 08:00:00 | BioLife Solutions to Report Second Quarter 2019 Financial Results and Provide Business Update on August 8, 2019

2019-07-30 08:00:00 | SAVSU Technologies Expands IP Portfolio with Risk Mitigation Technologies for Shipping Cell and Gene Therapies

2019-07-23 08:00:00 | SAVSU Technologies Partners with United Cargo® to Improve Cold Chain Management and Delivery of Cell and Gene Therapies

2019-07-08 16:31:45 | ABQ biotech firm to be acquired

2019-06-23 21:45:45 | Hedge Funds Have Never Been This Bullish On BioLife Solutions, Inc. BLFS

2019-06-10 08:00:00 | BioLife Solutions to Join Russell 3000® Index

2019-05-30 08:00:00 | BioLife Solutions to Present at the Jefferies 2019 Healthcare Conference

2019-05-29 08:00:00 | BioLife Solutions Announces SAVSU Technologies Selected by Novartis to Supply Advanced Cold Chain Management Platform for Newly Approved Gene Therapy

2019-05-09 21:54:30 | Edited Transcript of BLFS earnings conference call or presentation 9-May-19 8:30pm GMT

2019-05-09 20:24:22 | Biolife Solutions Inc BLFS Q1 2019 Earnings Call Transcript

2019-05-09 16:05:00 | BioLife Solutions Announces First Quarter 2019 Financial Results

2019-05-02 10:32:02 | BioLife Solutions BLFS to Report Q1 Results: Wall Street Expects Earnings Growth

2019-05-02 08:00:00 | BioLife Solutions to Report First Quarter 2019 Financial Results and Provide Business Update on May 9, 2019

2019-04-02 08:00:00 | BioLife Solutions Completes Acquisition of Astero Bio

2019-03-25 11:40:47 | Can BioLife Solutions, Inc. NASDAQ:BLFS Improve Its Returns?

2019-03-15 23:48:17 | BioLife Solutions Inc BLFS Files 10-K for the Fiscal Year Ended on December 31, 2018

2019-03-15 21:44:03 | Edited Transcript of BLFS earnings conference call or presentation 14-Mar-19 8:30pm GMT

2019-03-14 20:26:22 | Biolife Solutions Inc BLFS Q4 2018 Earnings Conference Call Transcript

2019-03-14 16:05:00 | BioLife Solutions Announces Fourth Quarter and Full Year 2018 Financial Results

2019-03-14 08:00:00 | BioLife Solutions Expands Cell and Gene Therapy Tools Portfolio with Acquisition of Astero Bio

2019-03-04 08:00:00 | BioLife Solutions to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on March 14, 2019

2019-02-19 08:00:00 | BioLife Solutions to Attend and Present at Upcoming Investor and Scientific Conferences

2019-02-08 08:57:01 | Here's Why You Should Invest in Stryker SYK Stock Right Now

2019-01-29 16:10:09 | Medical Products Industry Outlook: Plenty of Upside Left

2019-01-22 09:58:00 | SAVSU Technologies Launches Two New evo® Smart Shipper Models to Improve Apheresis Collection Shipments and Cryopreserved Cell and Gene Therapies

2019-01-22 08:00:00 | New Policies to Advance Development of Cell and Gene Therapies Announced by FDA

2019-01-11 08:53:01 | Medical Products Industry Gathering Steam: 3 Stocks to Buy

2018-12-11 08:00:00 | Consolidated Research: 2018 Summary Expectations for Enbridge Energy Partners, Sprouts Farmers Market, BioLife Solutions, PagSeguro Digital, NutriSystem, and Employers — Fundamental Analysis, Key Performance Indications

2018-11-27 08:00:00 | BioLife Solutions Completes Redemption of Series A Preferred Stock

2018-11-13 08:00:00 | BioLife Solutions to Attend and Present at Upcoming Scientific and Investor Conferences

2018-11-09 01:17:03 | Edited Transcript of BLFS earnings conference call or presentation 8-Nov-18 9:30pm GMT

2018-11-08 16:05:00 | BioLife Solutions Announces Third Quarter 2018 Financial Results

2018-11-05 08:08:01 | BioLife BLFS to Report Q3 Earnings: What's in the Cards?

2018-11-05 08:00:00 | SAVSU Technologies to Supply evo® Cold Chain Technologies to AveXis

2018-11-01 08:00:00 | BioLife Solutions to Report Third Quarter 2018 Financial Results and Provide Business Update on November 8, 2018

2018-10-18 07:40:00 | Market Trends Toward New Normal in Rambus, GMS, Advanced Energy Industries, AZZ, BioLife Solutions, and Spartan Motors — Emerging Consolidated Expectations, Analyst Ratings

2018-10-03 06:57:10 | BioLife Solutions Sees Hammer Chart Pattern: Time to Buy?

2018-10-01 08:00:00 | BioLife Solutions Reports Record Third Quarter 2018 Preliminary Revenue of $5.3 Million, up 79% Year-over-Year